Reddoch James F.
SEC CIK 1814872 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RPRX | Royalty Pharma plc | EVP, Research, Investments | 820.8K | — | $18.94M | 8 | 2021-07-06 | 2022-09-28 |
Most active insiders at RPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coyne Terrance P. | EVP, CFO | — | $38.96M |
| 2 | Hite Christopher | EVP, Vice COB | — | $27.36M |
| 3 | Lloyd George W. | EVP, CLO, Investments | — | $13.81M |
| 4 | Urist Marshall | EVP, Research, Investments | — | $12.07M |
| 5 | Norden Gregory | Dir | — | $161.4K |
| 6 | Engelbert Catherine M. | Dir | — | — |
| 7 | Ho Carole | Dir | — | — |
| 8 | Coric Vlad | Dir | — | — |
| 9 | Bassler Bonnie L | Dir | — | — |
| 10 | Legorreta Pablo G. | CEO, COB, Dir | — | — |
Reddoch James F. made no open-market trades at RPRX in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-09-30 | 2022-09-28 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, CSO | S - Sale | $41.23 | -100.0K | 820.8K | -11% | -$4.12M |
| I | 2022-06-10 | 2022-06-08 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, CSO | S - Sale | $41.56 | -100.0K | 920.8K | -10% | -$4.16M |
| I | 2022-05-31 | 2022-05-27 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, CSO | S - Sale | $41.08 | -75.0K | 1.02M | -7% | -$3.08M |
| I | 2022-05-23 | 2022-05-19 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, CSO | S - Sale | $40.44 | -75.0K | 1.10M | -6% | -$3.03M |
| I | 2021-07-27 | 2021-07-26 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research, Investments | S - Sale | $39.78 | -8,949 | 1.17M | -0.8% | -$356.0K |
| I | 2021-07-27 | 2021-07-26 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research, Investments | S - Sale | $39.78 | -8,949 | 1.17M | -0.8% | -$356.0K |
| MI | 2021-07-14 | 2021-07-12+ | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research, Investments | S - Sale | $42.01 | -17.9K | 1.18M | -1% | -$753.4K |
| MI | 2021-07-08 | 2021-07-06+ | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research, Investments | S - Sale | $42.19 | -73.1K | 1.24M | -6% | -$3.09M |
Purchase Sale Sale after option exercise All abbreviations